Clinical Trials Browser

Phase 2 × Palonosetron × CNS × Clear all

NCT00900757 2019-08-28

Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide

Phase 2 Completed

57 enrolled 10 charts

Glioma

NCT00636805 2014-04-01

Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab

Phase 2 Terminated

63 enrolled 11 charts

Brain Neoplasms